# NCT00297895 (NCT00297895)

> Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00297895
- Phase: NA
- Status: COMPLETED
- Sponsor: Saint John's Cancer Institute
- Conditions: Melanoma
- Interventions: Completion Lymphadenectomy; Monitoring with nodal ultrasound
- Enrollment: 1939
- Primary outcome: Melanoma-specific survival. This is defined as the time between the date of a subject's randomization (or date of CLND for those randomized to the CLND arm) and the date of death due to melanoma. Subjects are followed until death or 10yrs.

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 106
- Podcasts: 22
- YouTube: 12

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=nct00297895

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00297895", "email": "<work email>"}; the inbox owner confirms by the emailed link.